References
- Rumack B H, Ekins BR. Bupropion therapeutic/toxic class. Poisindix Information System, BH Rumack. Micromedex Inc, Denver, 11/30/95, Edition expires
- Spiller H A, Ramoska E A, Krenzelok E P. Bupropion overdose: a 3-year multi-center retrospective analysis. Am J Emerg Med 1994; 12: 43–45
- Friel P N, Logan B K, Fligner CL. Three fatal drug overdoses involving bupropion. J Anal Toxical 1993; 17: 436–438
- Rohrig T P, Ray NG. Tissue distribution of bupropion in a fatal overdose. J Anal Toxicol 1992; 16: 343–345
- Ramcharitar V, Levine B S, Goldberger B A, Caplan YH. Bupropion and alcohol fatal intoxication: case report. Forensic Sci Int 1992; 56: 151–156
- Van Wyck Fleet J, Manberg P J, Miller L L. Overview of clinically significant adverse reactions to bupropion. J Clin Psychiatry 1983; 44: 191–196
- Glassman A H, Preud'homme XA. Review of the cardiovascular effects of heterocyclic antidepressants. J Clin Psychiatry 1993; 54: 16–22
- Riou B, Kalfon P, Arock M, Goarin J P, Saada M, Viars P. Cardiovascular consequences of severe hypophosphataemia in brain-dead patients. Br J Anaesth 1995; 74: 424–429
- Brown G R, Greenwood JK. Drug- and nutrition-induced hypophosphatemia: mechanisms and relevance in the critically ill. Ann Pharmacother 1994; 28: 626–632
- Ognibene A, Ciniglio R, Greifenstein A. Ventricular tachycardia in acute myocardial infarction: the role of hypophosphatemia. South Med J 1994; 87: 65–69